Evidence map›Paper›PMID 31442052›Full record

ArticleJournal of proteome research2019

Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach.

Jaclyn R Daniels, Zhijun Cao, Mackean Maisha, Laura K Schnackenberg, Jinchun Sun, Lisa Pence, Thomas C Schmitt, Beate Kamlage, Sarah Rogstad, Richard D Beger and 1 more

Abstract read
In one paragraph

Article in Journal of proteome research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Large-scale circulating proteome association study (CPAS) meta-analysis identifies circulating proteins and pathways predicting incident hip fractures.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jaclyn R DanielsDivision of Systems Biology , National Center for Toxicological Research (NCTR) , U.S. Food and Drug Administration (FDA), Jefferson , Arkansas 72079 , United States.
Zhijun CaoDivision of Systems Biology , National Center for Toxicological Research (NCTR) , U.S. Food and Drug Administration (FDA), Jefferson , Arkansas 72079 , United States.
Mackean MaishaDivision of Bioinformatics & Biostatistics , NCTR, FDA , Jefferson , Arkansas 72079 , United States.
Laura K SchnackenbergDivision of Systems Biology , National Center for Toxicological Research (NCTR) , U.S. Food and Drug Administration (FDA), Jefferson , Arkansas 72079 , United States.
Jinchun SunDivision of Systems Biology , National Center for Toxicological Research (NCTR) , U.S. Food and Drug Administration (FDA), Jefferson , Arkansas 72079 , United States.ORCID 0000-0003-1466-605X
Lisa PenceDivision of Systems Biology , National Center for Toxicological Research (NCTR) , U.S. Food and Drug Administration (FDA), Jefferson , Arkansas 72079 , United States.
Thomas C SchmittDivision of Systems Biology , National Center for Toxicological Research (NCTR) , U.S. Food and Drug Administration (FDA), Jefferson , Arkansas 72079 , United States.
Beate KamlageMetanomics Health GmbH , Berlin 10589 , Germany.ORCID 0000-0003-2003-9036
Sarah RogstadCenter for Drug Evaluation and Research , FDA , Silver Spring , Maryland 20993 , United States.
Richard D BegerDivision of Systems Biology , National Center for Toxicological Research (NCTR) , U.S. Food and Drug Administration (FDA), Jefferson , Arkansas 72079 , United States.
Li-Rong YuDivision of Systems Biology , National Center for Toxicological Research (NCTR) , U.S. Food and Drug Administration (FDA), Jefferson , Arkansas 72079 , United States.ORCID 0000-0001-6084-991X

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

Variable processing and storage of whole blood and/or plasma are potential confounders in biomarker development and clinical assays. The goal of the study was to investigate how pre-analytical variables impact the human plasma proteome. Whole blood obtained from 16 apparently healthy individuals was collected in six EDTA tubes and processed randomly under six pre-analytical variable conditions including blood storage at 0 °C or RT for 6 h (B6h0C or B6hRT) before processing to plasma, plasma storage at 4 °C or RT for 24 h (P24h4C or P24hRT), low centrifugal force at 1300 ×

Indexed as

Protein StabilityAdultAptamers, PeptideBlood PreservationBlood Specimen CollectionComplement ActivationHealthy VolunteersHumansPlasmaProteomeProteomicsAptamers, PeptideProteomeaptamer technologybiomarkershuman bloodplasmapre-analytical variabilityproteomicsquality assessment

Identifiers

PMID31442052
PMCPMC8480202

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.